Challenging Contrast-Enhanced Mammography-Guided Biopsies: Practical Approach Using Real-Time Multimodality Imaging and a Proposed Procedural Algorithm.

Contrast-enhanced mammography (CEM) is an emerging functional breast imaging technique that entails the acquisition of dual-energy digital mammographic images after IV administration of iodine-based contrast material. CEM-guided biopsy technology was introduced in 2019 and approved by the FDA in 2020. This technology's availability enables direct sampling of suspicious enhancement seen only on, or predominantly on, recombined CEM images and addresses a major obstacle to the clinical implementation of CEM technology. Scarce literature has described clinical indications and procedural techniques of CEM-guided biopsy. This article describes our initial experience in performing challenging CEM-guided biopsies and proposes a step-by-step procedural algorithm designed to proactively address anticipated technical difficulties and thereby increase the likelihood of achieving successful targeting.